Alopecia associated with ritonavir-boosted atazanavir therapy

被引：3
|
作者：
Torres, Harrys A.
Barnetth, Ben J.
Arduino, Roberto C.
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infec Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Houston Med Sch, Dept Internal Med,Div Infect Dis, Houston, TX USA
来源：
AIDS | 2007年 / 21卷 / 10期
关键词：
D O I：
10.1097/QAD.0b013e3281532b42
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1391 / 1392
页数：2
相关论文
共 50 条
  • [31] Effect on lipids and reverse cholesterol transport of switching to unboosted atazanavir vs remaining on ritonavir-boosted atazanavir in regimens with a tenofovir backbone
    Harris, M.
    Saeedi, R.
    Ganase, B.
    Yousefi, M.
    Dubland, J.
    Francis, G. A.
    Guillemi, S.
    Hull, M.
    Montaner, J. S. G.
    ANTIVIRAL THERAPY, 2014, 19 : A5 - A6
  • [32] Lack of interaction between atazanavir and proton pump inhibitors in HIV-infected patients treated with ritonavir-boosted atazanavir - Response
    Khanlou, H
    Louie, S
    Farthing, C
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (03) : 394 - 394
  • [33] Dual therapy with dolutegravir plus ritonavir-boosted or unboosted atazanavir as a maintenance treatment in highly experienced HIV-infected patients
    Faycal, A.
    Abdi, B.
    Peytavin, G.
    Tebano, G.
    Schneider, L.
    Seang, S.
    Simon, A.
    Tubiana, R.
    Valantin, M.
    Marcelin, A.
    Katlama, C.
    Palich, R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [34] Antiretroviral Therapy with Ritonavir-Boosted Atazanavir- and Lopinavir-Containing Regimens Correlates with Diminished HIV-1 Neutralization
    Yuste, Eloisa
    Gil, Horacio
    Garcia, Felipe
    Sanchez-Merino, Victor
    VACCINES, 2024, 12 (10)
  • [35] Tipranavir: A ritonavir-boosted protease inhibitor
    Hicks, C
    DRUGS, 2005, 65 (12) : 1678 - 1678
  • [36] Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients
    Squires, Kathleen E.
    Young, Benjamin
    DeJesus, Edwin
    Bellos, Nicholaos
    Murphy, Daniel
    Zhao, Henry H.
    Patel, Lisa G.
    Ross, Lisa L.
    Wannamaker, Paul G.
    Shaefer, Mark S.
    AIDS, 2010, 24 (13) : 2019 - 2027
  • [37] Rifampicin interaction with ritonavir-boosted saquinavir
    Reactions Weekly, 2005, 1039 (1) : 4 - 4
  • [38] Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen
    Ghosn, Jade
    Carosi, Giampiero
    Moreno, Santiago
    Pokrovsky, Vadim
    Lazzarin, Adriano
    Pialoux, Gilles
    Sanz-Moreno, Jose
    Balogh, Agnes
    Vandeloise, Eric
    Biguenet, Sophie
    Leleu, Ghislaine
    Delfraissy, Jean-Francois
    ANTIVIRAL THERAPY, 2010, 15 (07) : 993 - 1002
  • [39] The outcome of switching from ritonavir boosted lopinavir to ritonavir boosted atazanavir or darunavir
    Rockwood, N.
    Singh, G. Jagjit
    Mandhalia, S.
    Nelson, M.
    HIV MEDICINE, 2012, 13 : 75 - 75
  • [40] TipranavirA Ritonavir-Boosted Protease Inhibitor
    Katherine F. Croom
    Susan J. Keam
    Drugs, 2005, 65 : 1669 - 1677
12345